act as opportunistic skin pathogens in humans and animals. Malassezia pachydermatis proliferation and phospholipase production may play a pathogenic role in the occurrence of skin lesions in dogs. This study investigates the presence of μ-opioid receptor (MOR) in M. pachydermatis strains isolated from healthy dogs and dogs with skin lesions and its effects on phospholipase activity (p.a.). P.a. of 64 M. pachydermatis isolates was evaluated using different concentrations of naloxone (Nx), a MOR antagonist. Isolates were divided into Group A (i.e., 40 isolates from 26 dogs with dermatitis) and Group B (i.e., 24 isolates from 12 healthy dogs). The MOR expression was analyzed by Western blot and immunofl uorescence. A statistically higher p.a. than that of the controls was found with isolates in Group A at a Nx concentration of 10 −6 M ( P Ͻ0.05). No isolate in Group B displayed p.a. in either control samples or in the presence of any Nx concentration. Immunoblotting revealed two positive MOR immunoreactive bands of approximately 65 and 98 kDa. MOR expression and localization was also demonstrated by immunofl uorescence in isolates from Groups A and B. This study provides the fi rst evidence of MOR expression on M. pachydermatis cell membranes pointing to its possible role in modulating p.a. production in isolates from dogs with skin lesions.
chemical or immunological mechanisms of the host may restrict bacterial colonization of the skin, thus favoring the overgrowth of yeasts [ 1 ] . The proliferation of Malassezia is likely to be a fi rst step toward dermatitis [ 2 ,3 ] . Evidence of phospholipase production in Malassezia pachydermatis only in isolates recovered from dogs with dermatitis but not from healthy animals suggests that these enzymes play a part in the occurrence of lesions [ 4 ] . G-protein associated with opioid receptors (e.g., μ opioid receptor -MOR) at the cellular membrane level has been known to modulate the activity of some phospholipases (i.e., C and A 2 ) [ 5 ,6 ] . Endogenous opioid peptides [ 5 -7 ] , such as ␤-endorphin, have a high affi nity with MOR and may affect multiple physiological
Introduction
Malassezia spp. are lipophilic yeasts which are part of the normal cutaneous microfl ora of most warmblooded animals and sometimes act as opportunistic pathogens [ 1 ] . The pathogenic role of Malassezia is unknown, although the changes in the normal physical, functions in both the central nervous system and peripheral tissues [ 8, 9 ] .
More specifi cally, MOR in human melanocytes, keratinocytes and nerve endings has been found to modulate interactions between the nervous system, keratinocytes and the cutaneous immune system [ 10 -13 ] . Mammalian skin has the intrinsic ability to express pro-opiomelanocortin (POMC), the precursor to β-endorphin [ 8 ,9 ] . Indeed, serum and skin concentrations of ␤-endorphin increase in some human skin diseases, such as psoriasis, atopic dermatitis and other infl ammatory dermatoses [ 11 ,14-6 ] . It has been suggested that the pathogenesis of these types of skin diseases may be affected by ␤endorphin through their effect on the MOR expression on keratinocytes [ 10 ,11 ] . Furthermore, ␤-endorphin might play a role in inducing M. pachydermatis cell differentiation towards the production or non-production of phospholipase [ 17 ] .
MOR expression in humans and animals was investigated by means of immunocytochemistry, immunoblotting and by RT-PCR, and its functional role was tested by means of agonist or antagonist compounds such as -endorphin and naloxone (Nx) [ 18 -21 ] . Nx is a MOR antagonist [ 22 ] characterized by having opposite effects according to concentration [ 23, 24 ] .
No information is currently available on the expression of MOR on M. pachydermatis cell membranes. Thus, the aim of the present work was to study MOR expression on the membranes of M. pachydermatis cells and its role in modulating phospholipase activity (p.a.) in yeasts isolated from healthy dogs and those with skin lesions.
Materials and methods
All chemicals were purchased from Sigma, Milan, Italy unless otherwise indicated.
Fungal strains and in vitro phospholipase activity evaluation
From October 2006 to May 2007, 64 isolates of M. pachydermatis were analyzed and categorized following p.a. recording [ 17 ] . The strains were divided into the following groups; Group Aϭ40 isolates showing p.a. from lesional skin of 26 dogs with dermatitis confi ned to one anatomical site and Group Bϭ24 isolates not showing p.a. taken from the skin of 12 healthy dogs. Phospholipase production was assessed by means of the egg-yolk plate method as previously reported [ 17 ] . Briefl y, the isolates were incubated on slants of Dixon agar (three days at 32°C) and suspended in Dixon broth (colony forming units: 2.5ϫ10 3 ϫml −1 ) to which was added different concentrations (from 10 −3 to 10 −9 M) of Nx, with the latter incubated for three days at 32°C. Ten μl of yeast suspensions were then added to the egg-yolk plates and incubated at 32°C. Readings were taken after 10 days and the formation of zones of precipitation around the colonies was considered to be indicative of enzyme production. Phospholipase production was expressed as a ratio (Pz) of colony diameter (a) to total diameter of the colonies plus zone of precipitation (b) [ 17 ] . Hence, the higher the Pz value, the lower the production of phospholipases. Each strain was tested in duplicate and the Pz recorded as an average of the two Pz values for each isolate. P.a. was expressed as a mean of Pz values. Isolates suspended in Dixon broth without the addition of Nx were used as controls.
MOR expression study
Western blot analysis was performed on proteins extracted from clones of cultured Malassezia yeast cells, the fi rst from Group A (code number CD47) and the second from Group B (code number CD73). The isolates were incubated on Dixon agar (three days at 32°C) and suspended in Dixon broth (colony forming units: 2.5ϫ10 3 ϫml −1 ) and then re-incubated for three days at 32°C. The yeast suspension was centrifuged at 1,700 g for 10 min and supernatant was removed. Pelleted cells underwent 5 freeze/thaw (liquid nitrogen/95°C) cycles before homogenization in a 4°C cold lysis buffer (0.5% Nonidet P-40; 8M urea; 0.1% Tween 20; 30mM N-octyl-␤-D-glycopyranoside; 0.5% triton X-100; 1% sodium dodecyl sulfate -SDS) pH 7.2 containing protease inhibitors (1μg/ml pepstatin A; 1μg/ml leupeptin; 1μg/ml aprotinin; 100μg/ml phenyl methane sulfonyl fl uoride; 100μg/ml benzamidine; 8μg/ml calpain I and II). The homogenate was centrifuged at 10,000 g for 30 min at 4°C to remove cellular debris. Protein concentration of the supernatant was measured using a bicinchoninic acid assay (Pierce, Milan, Italy). An aliquot of 40 μg protein was loaded on a precast 4-12% SDS/PAGE (Bio-Rad, Hercules, CA, USA). Following electrophoresis, proteins were electrotransferred (semi-dry apparatus, BioRad) to Immobilon-P membranes (Millipore, Bedford, MA, USA). Membranes were blocked in a solution of 20 mM Tris-HCl, pH 7.5; 0.15M NaCl; 1% Triton X-100; 5% non-fat milk (blocking buffer) for 1 h and blotted overnight at 4°C against the primary rabbit polyclonal antibody against the third extracellular loop of the mouse MOR (Chemicon Int. Inc. Temecula, CA, USA) diluted 1:7,500 in blocking buffer. Membranes were washed in blocking buffer and incubated with a 1:10,000 dilution of peroxidase-conjugated goat anti-rabbit secondary antibody for 2 h at room temperature. After washing, reactive bands were visualized by Supersignal West Pico Chemiluminescent Substrate (Pierce, Milan, Italy). Proteins from rat brains were used as a positive control [ 19 ] . After revelation, each membrane was treated with Restore Western blot stripping buffer (Pierce) for 15 min at 37°C and than washed with 0.01% Tween 20 in PBS to remove the immunocomplex. After another exposure to verify the effi cacy of the removal treatment, membranes were hybridized with the anti-beta-actin antibody diluted 1:30,000 and revealed as described above. The anti-beta-actin antibody was used to normalize the intensity of MOR expression signals, thus eliminating any difference due to manual operatorintrusion. Normalization of the signals obtained was performed with Software Quantity-One (BioRad). For immunofl uorescence, fi ve microliters of the Dixon broth cell suspension obtained as described above were smeared in duplicate onto poly-L-lysine coated slides. Smears were fi xed for 10 min in 4% (v/v) paraformaldehyde and blocked for 30 min in PBS containing 1% BSA. Each sample was incubated overnight at room temperature with the primary rabbit polyclonal antibody against the third extracellular loop of the mouse MOR (Chemicon Int. Inc.) diluted 1:2,500. After washing, samples were incubated with a goat-anti rabbit-FITC conjugated secondary antibody diluted 1:200 in Evans Blue in order to counterstain negative cells. Negative controls were incubated overnight in PBS containing 1% BSA without the primary antibody. After the treatment with the secondary antibody all samples were examined for fl uorescence patterns by means of a C1 confocal laser scanning module equipped with dedicated software (Nikon, Tokio, Japan).
Statistical analysis
The Chi-square test was used to compare the number of isolates within each group producing phospholipase at different Nx concentrations with the control samples. The analysis of variance (ANOVA), followed by Tukey's Post Hoc Test, was used to evaluate the differences among Pz mean values at different Nx concentrations of strains within each group (A, B) , and their controls. A value of P Յ0.05 was considered to be statistically signifi cant.
Results
The number of isolates producing phospholipase in Group A decreased signifi cantly at Nx concentrations equal to or lower than 10 −8 M ( Table 1 ) . In Group A, all control isolates showed p.a. with Pzϭ0.74. Statistically lower Pz values were observed at Ͻ10 −6 M Nx, while they were statistically higher at 10 −9 M ( Table 1 ) . In Group B, no isolate showed p.a. in either the control or in the presence of any concentration of Nx. Immunostaining for MOR was observed in both analyzed clones (CD43 and CD73) over the surface of the cells ( Fig. 2 a,b) . No fl uorescence signal was observed when the primary antibody was omitted ( Fig. 2 c) , demonstrating the absence of non-specifi c immune labeling by the secondary antibody.
Discussion
The results of the present study provide the fi rst evidence of the presence of MOR on M. pachydermatis cell membrane, and they suggest its role in modulating the p.a. of this yeast. Indeed, immunoblotting and immunofl uorescence analysis both reveal comparable MOR expression in clones of isolates taken from both Groups A and B, which would suggest that MOR is expressed on M. pachydermatis cell membranes ( Figs. 1 and 2 ) . MOR proteins are known to undergo different post-translational modifi cations such as phosphorylation, glycosylation or dimerization with other opioid receptors (e.g., ␦-opioid receptor -DOR protein) [ 25 ] . Consequently, the 98 kDa band could be the result of alterations of this sort in the two yeast clones analyzed and its higher expression in the clone from Group B. It is commonly thought that multiple factors (e.g., transmembrane domain hydrophobicity, extracellular disulphide bonds, intracellular coiled-coil interactions and the agonist concentration) cooperatively mediate the opioid receptor oligomerization [ 25, 26 ] . Under the above circumstances, the differences observed between clones from Groups A and B may refl ect the differences in chemical composition of the skin from which the isolates were recovered. Indeed, the biochemical composition of canine skin may vary according to its health and integrity [ 1 ] . In humans, a statistically signifi cant greater amount of ␤-endorphin has been found in the skin and blood of patients with atopic dermatitis [ 11 ,13, 15 ] . Similarly, a high concentration of ␤-endorphin on lesions of the skin in dogs (Group A) could have infl uenced the expression of yeast cell membrane receptors.
Furthermore, our results suggest that MOR plays a part in modulating the p.a. in M. pachydermatis isolates. The dual effect of Nx [ 23 ] in inducing an increase in p.a. at Using Western blot analysis, a band corresponding to MOR protein (with a molecular weighting of about 65 kDa) was observed in the protein fraction obtained from both clones, CD47 and CD73 ( Fig. 1 a) . An additional band of around 98kDa was also detected, with a higher expression in the clone from Group B than that from Group A. No immunoreactivity was observed with the antiserum depleted of its anti-MOR antibody by preadsorption with a molar excess of the immunizing peptide (negative control; Ablanes in Fig. 1 c) . Two bands with the same molecular weight were observed in homogenates prepared from rat brain (positive control; Fig. 1 b) . Semi-quantitative analysis was performed, normalizing the intensity of MOR signals to those obtained after hybridization for beta-actin ( Fig. 1 d) . high concentrations (10 −3 and 10 −6 M) and a decrease at low concentrations (10 −9 M) has been also recorded in isolates from skin lesions (Group A). Conversely, Nx did not modulate p.a. in isolates from healthy skin (Group B). This phenomenon could be related to different MOR expressions on the cell membrane of M . pachydermatis isolates from Groups A and B.
The MOR is a transmembrane G-protein-coupled receptor (GPCR) responsible for transducing extracellular signals into intracellular responses [ 27 ] . Following recent advances in fungal genome sequencing projects, a panoply of GPCR candidates has been also revealed in opportunistic yeasts such as Candida species and Cryptococcus neoformans 27 ]. Some of these receptors play key roles sensing diverse extracellular signals, such as pheromones, sugars, amino acids, nitrogen sources, and even photons [ 27 ] . The presence of MOR in M. pachydermatis has been documented for the fi rst time in this study although the effect of agonists, such as ␤-endorphin, had already been reported for Candida albicans suggesting that ␤-endorphin concentrations may determine its differentiation from yeast to the mycelial form [ 28 ] . This study suggests that opioid receptors are present in isolates of M. pachydermatis and may be involved in mediating the effects of opioid agents. Their expression mechanisms might be strictly related to the chemical composition of the skin and may have a role in infl uencing the pathogenic or commensal phenotype of Malassezia . Further functional investigations of opioid receptors and their expression mechanism could raise hypotheses about pathogenic processes in animals colonized by M. pachydermatis , thus opening new avenues for the topical control of Malassezia lesions.
